Elevance Health, Inc. ELV reported fourth-quarter 2024 adjusted earnings per share (EPS) of $3.84, which surpassed the Zacks Consensus Estimate by 1.1%. However, the bottom line deteriorated 31.7% ...

Elevance Health Inc.'s stock rose 2% Thursday and boosted other health-insurance stocks after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor concerns ...

The company’s medical loss ratio, which tracks the proportion of premiums paid out to cover medical costs, was 92.4% in the fourth quarter. That is up from 89.2% in the same qua ...

Elevance Health's financial outlook for FY 2025 anticipates GAAP diluted earnings per share (EPS) to be in the range of $30.40 to $31.10 and adjusted diluted EPS to be in the range of $34.15 to $34.85 ...

The prior authorization was denied. What’s more, in an unusual move, the insurer declined to allow a “peer-to-peer” review of her case between her physician and one working for her insurer.

UnitedHealth Group (NYSE:UNH – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a ...

Individuals who don’t get coverage from employers or government programs tap federal tax credits via the state’s health ...